# FDA Warning Letter: Flowchem Pharma Private Limited
> 2026-03-17 · Center for Drug Evaluation and Research (CDER) · `f1b6c9b13fce65c5`
## Letter
- **Company:** Flowchem Pharma Private Limited
- **Posted Date:** 2026-03-17
- **Letter Issue Date:** 2026-03-11
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*